Robert Hodgson
Director, In Vivo CNS, Integrated Drug Discovery
General Science
Technical University of Denmark
France
Biography
Rober “Sandy” Hodgson specializes in behavioral pharmacology, PK/PD and in vitro-in vivo correlations, microdialysis, and electrophysiology. For more than 15 years, Sandy has been immersed in CNS drug discovery and is passionate about the advancement of novel therapies to treat the significant unmet need in CNS diseases. Prior to Charles River, he worked in large pharma at Schering-Plough and Merck, leading and contributing to CNS drug discovery programs, primarily in the areas of psychiatry and neurology. During that time, his team was the primary driver of in vivorodent and large animal models that would provide the core data to support the advancement of novel therapies toward clinical studies. Dr. Hodgson has been a member of the Society of Neuroscience as well as a grant reviewer for the Michael J. Fox Foundation. His research has yielded 40 peer-reviewed papers.
Research Interest
Behavioral pharmacology, PK/PD and in vitro-in vivo correlations, microdialysis, and electrophysiology.
